Report Detail

Medical Devices & Consumables COVID-19 Impact on Urethral Bulking System Market, Global Research Reports 2020-2021

  • RnM3973755
  • |
  • 22 May, 2020
  • |
  • Global
  • |
  • 93 Pages
  • |
  • XYZResearch
  • |
  • Medical Devices & Consumables

Urinary incontinence is a health issue experienced usually in women. In this condition the patient experience urine leakage due to pressure on urethra and bladder. Thus, frequent urination becomes a significant early symptom. 1 in 3 women at some point of time in their lives suffer from urinary incontinence. Aging increases the chances of urinary incontinence. Urethral incontinence is typically related with the economic burden and affect the quality of life. The treatment for urethral incontinence is usually surgery but with the growing advancement, the ureteral bulking systems has been proved as a better and advanced alternate to open surgery. These bulking systems help to resist the frequent urine flow. The bulking agents are injected in the periurethral wall and then solidifies to cover the wall of urethra, restricting the urine flow. Urethral bulking systems are usually made up of silicone beads, collagen, carbon particles, and polytetrafluoroethylene paste. Recently bulkamid, an injectable bulking agent has been proven effective for urethral incontinence.

This report provides a complete quantitative data and qualitative analysis on the global market for Urethral Bulking System. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Urethral Bulking System was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Urethral Bulking System is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Urethral Bulking System, including the following market information:
Global Urethral Bulking System Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Urethral Bulking System Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Urethral Bulking System Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Urethral Bulking System Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include CR Bard, Merz Aesthetics, Cogentix Medical, Q-Med, ASCENTX MEDICAL, INC., Coloplast Corp., Boston Scientific Corporation, AstraZeneca, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Endoscopic
Non- Endoscopic

Based on the Application:
Hospitals
Clinics
Ambulatory Surgical Centers
Others


  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Urethral Bulking System Industry
  • 1.7 COVID-19 Impact: Urethral Bulking System Market Trends
  • 2 Global Urethral Bulking System Quarterly Market Size Analysis

    • 2.1 Urethral Bulking System Business Impact Assessment - COVID-19
      • 2.1.1 Global Urethral Bulking System Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Urethral Bulking System Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Urethral Bulking System Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Urethral Bulking System Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Urethral Bulking System Market
    • 3.4 Key Players Urethral Bulking System Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Urethral Bulking System Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Endoscopic
      • 1.4.2 Non- Endoscopic
    • 4.2 By Type, Global Urethral Bulking System Market Size, 2019-2021

    5 Impact of Covid-19 on Urethral Bulking System Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospitals
      • 5.5.2 Clinics
      • 5.5.3 Ambulatory Surgical Centers
      • 5.5.4 Others
    • 5.2 By Application, Global Urethral Bulking System Market Size, 2019-2021
      • 5.2.1 By Application, Global Urethral Bulking System Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 CR Bard
      • 7.1.1 CR Bard Business Overview
      • 7.1.2 CR Bard Urethral Bulking System Quarterly Revenue, 2020
      • 7.1.3 CR Bard Urethral Bulking System Product Introduction
      • 7.1.4 CR Bard Response to COVID-19 and Related Developments
    • 7.2 Merz Aesthetics
      • 7.2.1 Merz Aesthetics Business Overview
      • 7.2.2 Merz Aesthetics Urethral Bulking System Quarterly Revenue, 2020
      • 7.2.3 Merz Aesthetics Urethral Bulking System Product Introduction
      • 7.2.4 Merz Aesthetics Response to COVID-19 and Related Developments
    • 7.3 Cogentix Medical
      • 7.3.1 Cogentix Medical Business Overview
      • 7.3.2 Cogentix Medical Urethral Bulking System Quarterly Revenue, 2020
      • 7.3.3 Cogentix Medical Urethral Bulking System Product Introduction
      • 7.3.4 Cogentix Medical Response to COVID-19 and Related Developments
    • 7.4 Q-Med
      • 7.4.1 Q-Med Business Overview
      • 7.4.2 Q-Med Urethral Bulking System Quarterly Revenue, 2020
      • 7.4.3 Q-Med Urethral Bulking System Product Introduction
      • 7.4.4 Q-Med Response to COVID-19 and Related Developments
    • 7.5 ASCENTX MEDICAL, INC.
      • 7.5.1 ASCENTX MEDICAL, INC. Business Overview
      • 7.5.2 ASCENTX MEDICAL, INC. Urethral Bulking System Quarterly Revenue, 2020
      • 7.5.3 ASCENTX MEDICAL, INC. Urethral Bulking System Product Introduction
      • 7.5.4 ASCENTX MEDICAL, INC. Response to COVID-19 and Related Developments
    • 7.6 Coloplast Corp.
      • 7.6.1 Coloplast Corp. Business Overview
      • 7.6.2 Coloplast Corp. Urethral Bulking System Quarterly Revenue, 2020
      • 7.6.3 Coloplast Corp. Urethral Bulking System Product Introduction
      • 7.6.4 Coloplast Corp. Response to COVID-19 and Related Developments
    • 7.7 Boston Scientific Corporation
      • 7.7.1 Boston Scientific Corporation Business Overview
      • 7.7.2 Boston Scientific Corporation Urethral Bulking System Quarterly Revenue, 2020
      • 7.7.3 Boston Scientific Corporation Urethral Bulking System Product Introduction
      • 7.7.4 Boston Scientific Corporation Response to COVID-19 and Related Developments
    • 7.8 AstraZeneca
      • 7.8.1 AstraZeneca Business Overview
      • 7.8.2 AstraZeneca Urethral Bulking System Quarterly Revenue, 2020
      • 7.8.3 AstraZeneca Urethral Bulking System Product Introduction
      • 7.8.4 AstraZeneca Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      Summary:
      Get latest Market Research Reports on Urethral Bulking System. Industry analysis & Market Report on Urethral Bulking System is a syndicated market report, published as COVID-19 Impact on Urethral Bulking System Market, Global Research Reports 2020-2021. It is complete Research Study and Industry Analysis of Urethral Bulking System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,500.00
      $7,000.00
      2,810.50
      5,621.00
      3,283.00
      6,566.00
      540,505.00
      1,081,010.00
      292,740.00
      585,480.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report